FMP

FMP

Enter

APRE - Aprea Therapeutics, ...

Terminal Value of Aprea Therapeutics, Inc.(APRE), Aprea Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and comm

photo-url-https://financialmodelingprep.com/image-stock/APRE.png

Aprea Therapeutics, Inc.

APRE

NASDAQ

Aprea Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel cancer therapeutics that target DNA damage response pathways. Its lead product candidate is ATRN-119, an oral ATR inhibitor that is in phase 1/2a clinical trial to treat patients with advanced solid tumors. The company's products pipeline also includes ATRN-Backup, an ATR inhibitor; ATRN-W1051 to treat anti-tumor activity; and ATRN-DDRi. Aprea Therapeutics, Inc. is based in Boston, Massachusetts.

4.2 USD

0.1 (2.38%)

FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedinfacebookinstagram
2017-2024 © Financial Modeling Prep